• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例与使用益生菌相关的D-乳酸脑病病例。

A case of D-lactic acid encephalopathy associated with use of probiotics.

作者信息

Munakata Shun, Arakawa Chikako, Kohira Ryutaro, Fujita Yukihiko, Fuchigami Tatsuo, Mugishima Hideo

机构信息

Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.

出版信息

Brain Dev. 2010 Sep;32(8):691-4. doi: 10.1016/j.braindev.2009.09.024. Epub 2009 Nov 14.

DOI:10.1016/j.braindev.2009.09.024
PMID:19917522
Abstract

A five year old girl was admitted to the hospital for evaluation of intermittent ataxia. She had undergone serial resections of the small intestine after birth, resulting in short bowel syndrome. Lactomin was prescribed for watery diarrhea at twice the regular dose 2 weeks before the onset of neurologic symptoms. D-lactic acidosis was diagnosed on the basis of a plasma D-lactate level of 5.537 mmol/l. Lactomin was discontinued, and she was treated with sodium bicarbonate and oral antibiotics. The probiotics the patient had taken were likely the cause of D-lactic acidosis and should therefore be avoided in patients with short bowel syndrome.

摘要

一名五岁女孩因间歇性共济失调入院评估。她出生后接受了多次小肠切除术,导致短肠综合征。在出现神经症状前两周,给予拉克托敏治疗水样腹泻,剂量为常规剂量的两倍。根据血浆D-乳酸水平5.537 mmol/l诊断为D-乳酸酸中毒。停用拉克托敏,并用碳酸氢钠和口服抗生素治疗。该患者服用的益生菌可能是D-乳酸酸中毒的原因,因此短肠综合征患者应避免使用。

相似文献

1
A case of D-lactic acid encephalopathy associated with use of probiotics.一例与使用益生菌相关的D-乳酸脑病病例。
Brain Dev. 2010 Sep;32(8):691-4. doi: 10.1016/j.braindev.2009.09.024. Epub 2009 Nov 14.
2
[D-lactic acidosis in a child with short bowel syndrome].[一名短肠综合征患儿的D-乳酸酸中毒]
Arch Pediatr. 2008 Feb;15(2):145-8. doi: 10.1016/j.arcped.2007.11.009. Epub 2008 Feb 1.
3
Recurrent D-lactic acidosis in a child with short bowel syndrome.一名短肠综合征患儿的复发性D-乳酸酸中毒
Asia Pac J Clin Nutr. 2005;14(2):195-8.
4
[D-Lactic acidosis secondary to short bowel syndrome].短肠综合征继发的D-乳酸酸中毒
Nutr Hosp. 2010 Sep-Oct;25(5):864-6.
5
D-lactic acidosis in short bowel syndrome--an examination of possible mechanisms.短肠综合征中的D-乳酸酸中毒——对可能机制的研究
Q J Med. 1990 Feb;74(274):157-63.
6
[D-lactic acidosis in short bowel syndrome].[短肠综合征中的D-乳酸酸中毒]
Harefuah. 1999 Mar 1;136(5):347-9, 420.
7
A 3-year-old boy with ataxia.一名患有共济失调的3岁男孩。
Pediatr Emerg Care. 2015 Mar;31(3):220-1. doi: 10.1097/PEC.0000000000000384.
8
D-lactic acidosis: an unusual cause of encephalopathy in a patient with short bowel syndrome.D-乳酸酸中毒:短肠综合征患者脑病的一种罕见病因。
Acta Clin Belg. 2013 May-Jun;68(3):229-31. doi: 10.2143/ACB.3217.
9
D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics.使用抗生素和益生菌治疗短肠综合征中的D-乳酸酸中毒。
J Pediatr Surg. 2004 Apr;39(4):634-6. doi: 10.1016/j.jpedsurg.2003.12.026.
10
D-Lactic acidosis 25 years after bariatric surgery due to Salmonella enteritidis.肠杆菌性食物中毒导致减重手术后 25 年发生 D-乳酸酸中毒
Nutrition. 2012 Jan;28(1):108-11. doi: 10.1016/j.nut.2011.07.005. Epub 2011 Oct 12.

引用本文的文献

1
Unveiling the Interplay Between the Human Microbiome and Gastric Cancer: A Review of the Complex Relationships and Therapeutic Avenues.揭示人类微生物组与胃癌之间的相互作用:复杂关系及治疗途径综述
Cancers (Basel). 2025 Jan 12;17(2):226. doi: 10.3390/cancers17020226.
2
Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review.用于治疗肠易激综合征的益生菌和益生元——一篇叙述性综述
J Clin Med. 2024 Oct 23;13(21):6337. doi: 10.3390/jcm13216337.
3
Probiotics and Paraprobiotics: Effects on Microbiota-Gut-Brain Axis and Their Consequent Potential in Neuropsychiatric Therapy.
益生菌和副益生菌:对微生物群-肠道-大脑轴的影响及其在神经精神治疗中的潜在应用。
Probiotics Antimicrob Proteins. 2024 Aug;16(4):1440-1464. doi: 10.1007/s12602-024-10214-6. Epub 2024 Jan 31.
4
Emerging issues in probiotic safety: 2023 perspectives.益生菌安全性的新问题:2023 年的观点。
Gut Microbes. 2023 Jan-Dec;15(1):2185034. doi: 10.1080/19490976.2023.2185034.
5
In vitro assessment of probiotic attributes for strains contained in commercial formulations.商业制剂中所含菌株的益生菌特性的体外评估。
Sci Rep. 2022 Dec 14;12(1):21640. doi: 10.1038/s41598-022-25688-z.
6
Considerations for determining safety of probiotics: A USP perspective.确定益生菌安全性的考虑因素:USP 的观点。
Regul Toxicol Pharmacol. 2022 Dec;136:105266. doi: 10.1016/j.yrtph.2022.105266. Epub 2022 Oct 4.
7
Infection Prevention and Management in Pediatric Short Bowel Syndrome.小儿短肠综合征的感染预防与管理
Front Pediatr. 2022 Jun 30;10:864397. doi: 10.3389/fped.2022.864397. eCollection 2022.
8
The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis.脂肪酸代谢产物在阴道健康与疾病中的作用:在念珠菌病中的应用
Front Microbiol. 2021 Jul 2;12:705779. doi: 10.3389/fmicb.2021.705779. eCollection 2021.
9
Human d-lactate dehydrogenase deficiency by mutation in a patient with neurological manifestations and mitochondrial complex IV deficiency.一名患有神经学表现和线粒体复合物IV缺乏症的患者因突变导致人类d-乳酸脱氢酶缺乏。
JIMD Rep. 2021 May 21;60(1):15-22. doi: 10.1002/jmd2.12220. eCollection 2021 Jul.
10
Probiotics in the Prevention and Treatment of Necrotizing Enterocolitis.益生菌在坏死性小肠结肠炎预防和治疗中的应用
Pediatr Gastroenterol Hepatol Nutr. 2021 May;24(3):245-255. doi: 10.5223/pghn.2021.24.3.245. Epub 2021 May 4.